Read the Beforeitsnews.com story here. Advertise at Before It's News here.
Profile image
By ProactiveInvestors (Reporter)
Contributor profile | More stories
Story Views
Now:
Last hour:
Last 24 hours:
Total:

Biocept's validation testing of Target Selector for cancer mutations published in peer-review journal

% of readers think this story is Fact. Add your two cents.


Biocept Inc (NASDAQ:BIOC), a liquid biopsy provider, announced Monday that a peer-review journal published validation results showing the high sensitivity of its Target Selector testing for EGFR, BRAF and KRAS mutations in plasma circulating tumor DNA (ctDNA). 

The company said the article was published in the journal PLOS ONE this month and will also be included as part of a special collection of topical articles entitled Targeted Anticancer Therapies And Precision Medicine In Cancer.

In a statement, Biocept said Target Selector testing for EGFR, BRAF, and KRAS mutations has been validated to an ultra-sensitive single copy level, with a limit of detection (LOD) of 0.02% or better.

READ: Biocept wins South Korea patent for its Switch-Block technology used to detect rare cancer mutations

The San Diego-based company’s biomarker tests provide coverage for the most common actionable mutations associated with clinical guidelines for targeted cancer therapy.

Target Selector tests performed in Biocept’s laboratory provide a commercial turnaround time of 3-4 days, and offer a cost-effective strategy to guide treatment decisions and monitor therapeutic response.  At the core of Target Selector is the company’s Switch-Blocker technology, used in detecting rare cancers associated with mutations.

“Biocept’s patented Switch-Blocker technology uniquely amplifies mutations of interest from the blood of patients with cancer, while blocking wild type DNA. This enables very high sensitivity and detection down to a single gene copy,” said Jason Poole, Biocept’s vice president of research and development and the study’s lead author.

“We are very pleased to have this analytical validation published in PLOS ONE, and believe the results demonstrate the high sensitivity and performance of our novel liquid biopsy assays, which are designed to provide oncologists with the information they need to select the right targeted therapy for their patients.”

CEO Michael Nall noted that Target Selector liquid biopsies “continues to emerge as an important tool to cost-effectively qualify patients for therapy and, importantly, monitor therapeutic response and disease progression for physicians and their patients with cancer.” 

Contact the author: [email protected]

Follow him on Twitter @PatrickMGraham

Story by ProactiveInvestors


Source: https://www.proactiveinvestors.com/companies/news/904282/biocept-s-validation-testing-of-target-selector-for-cancer-mutations-published-in-peer-review-journal-904282.html


Before It’s News® is a community of individuals who report on what’s going on around them, from all around the world.

Anyone can join.
Anyone can contribute.
Anyone can become informed about their world.

"United We Stand" Click Here To Create Your Personal Citizen Journalist Account Today, Be Sure To Invite Your Friends.

Please Help Support BeforeitsNews by trying our Natural Health Products below!


Order by Phone at 888-809-8385 or online at https://mitocopper.com M - F 9am to 5pm EST

Order by Phone at 866-388-7003 or online at https://www.herbanomic.com M - F 9am to 5pm EST

Order by Phone at 866-388-7003 or online at https://www.herbanomics.com M - F 9am to 5pm EST


Humic & Fulvic Trace Minerals Complex - Nature's most important supplement! Vivid Dreams again!

HNEX HydroNano EXtracellular Water - Improve immune system health and reduce inflammation.

Ultimate Clinical Potency Curcumin - Natural pain relief, reduce inflammation and so much more.

MitoCopper - Bioavailable Copper destroys pathogens and gives you more energy. (See Blood Video)

Oxy Powder - Natural Colon Cleanser!  Cleans out toxic buildup with oxygen!

Nascent Iodine - Promotes detoxification, mental focus and thyroid health.

Smart Meter Cover -  Reduces Smart Meter radiation by 96%! (See Video).

Report abuse

    Comments

    Your Comments
    Question   Razz  Sad   Evil  Exclaim  Smile  Redface  Biggrin  Surprised  Eek   Confused   Cool  LOL   Mad   Twisted  Rolleyes   Wink  Idea  Arrow  Neutral  Cry   Mr. Green

    MOST RECENT
    Load more ...

    SignUp

    Login

    Newsletter

    Email this story
    Email this story

    If you really want to ban this commenter, please write down the reason:

    If you really want to disable all recommended stories, click on OK button. After that, you will be redirect to your options page.